Categories: Uncategorized

Breaking: DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years

The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covaxin (COVID vaccine) in the age group 2 to 18 years, to its manufacturer Bharat Biotech Ltd on 12.05.2021.
M/s Bharat Biotech International Ltd., Hyderabad (BBIL) had proposed to carry out a Phase- II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers.
In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28.
As rapid regulatory response, the proposal was deliberated in Subject Expert Committee (SEC) (COVID-19) on 11.05.2021. The Committee after detailed deliberation recommended for grant of permission to conduct proposed Phase II/III clinical trial to certain conditions.

Medically Speaking Team

Recent Posts

One Sleepless Night Can Weaken Your Immunity and Trigger Inflammation

Sleep is often regarded as a luxury in today’s fast-paced world, but scientific research continuously…

2 days ago

Thick Heart Syndrome: A Silent Threat to Millions in India

Heart disease remains one of the leading causes of death worldwide, and in India, cardiovascular…

2 days ago

Delhi Sees Surge in H1N1 and Influenza B Cases

Delhi is witnessing a sharp rise in flu cases, particularly Influenza B and H1N1 (commonly…

2 days ago

Woman Dies During MRI Scan Due to Medical Negligence

In early February 2025, a tragic incident occurred in Eluru, Andhra Pradesh, where a 61-year-old…

2 days ago

Holi and Eye Safety: Protect Your Vision During Festivities

Holi, the festival of colors, is one of the most vibrant and joyous celebrations in…

3 days ago

FDA Recalls Popular Skincare Products Over Cancer-Causing Chemical

In a major development, the U.S. Food and Drug Administration (FDA) has issued recalls for…

3 days ago